PLD2 and cancer: A range of other single nucleotide polymorphisms, evident in both PLD1 and PLD2, are also listed in Catalogue of Somatic Mutations in Cancer (Tate et al., 2019; Table S1), and further changes in CIZ1 are linked with both benign (Wang et al., 2019) and malignant (Chen et al., 2020; Liu et al., 2015; Wang et al., 2014; Wu et al., 2016; Zhang et al., 2014) tumors.